RNAC
Cartesian Therapeutics·NASDAQ
--
--(--)
--
--(--)
RNAC fundamentals
Cartesian Therapeutics (RNAC) released its earnings on Aug 7, 2025: revenue was 298.00K (YoY -99.10%), missed estimates; EPS was 0.5 (YoY -7.41%), beat estimates.
Revenue / YoY
298.00K
-99.10%
EPS / YoY
0.5
-7.41%
Report date
Aug 7, 2025
EPS
Actual | -6.3 | -7.5 | -2.7 | -4.2 | -6.6 | 0 | -4.8 | 3 | 6.9 | 1.8 | -1.5 | 1.2 | -4.2 | -2.1 | -1.35 | -2.17 | -10.5 | 0.54 | -1.13 | -0.68 | 0.5 | ||||||||||||
Forecast | -8.3537 | 0.5813 | 2.9571 | -3.7286 | -3.65 | -3.5143 | -2.2286 | -2.455 | -3.351 | -2.2714 | -0.1714 | -2.1699 | -2.6 | -3.6 | -2.34 | -0.9 | -0.885 | -0.8629 | -0.8017 | -0.7013 | -0.8029 | ||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +24.58% | -1390.21% | -191.31% | -12.64% | -80.82% | +100.00% | -115.38% | +222.20% | +305.91% | +179.25% | -775.15% | +155.30% | -61.54% | +41.67% | +42.31% | -141.11% | -1086.44% | +162.58% | -40.95% | 0.00% | +3.04% | +162.27% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 4.65M | 12.00M | 11.10M | 19.66M | 24.43M | 29.94M | 34.00M | 39.30M | 20.71M | 16.80M | 5.94M | 5.25M | 5.88M | 8.27M | 5.84M | 33.27M | 387.00K | -- | 1.10M | 298.00K |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 25.00M | 27.92M | 5.46M | 6.27M | 7.13M | 12.19M | 17.23M | 12.14M | 13.78M | 25.21M | 11.68M | 12.14M | 5.60M | 7.23M | 2.50M | 1.67M | 6.61M | 1.25M | -- | 916.67K | 928.57K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -83.36% | +119.73% | +76.92% | +175.75% | +100.44% | +73.74% | +180.08% | +185.17% | -17.86% | +43.74% | -51.08% | -6.27% | -18.74% | +230.64% | +250.40% | +403.34% | -69.04% | 0.00% | +20.00% | -67.91% |
Earnings Call
You can ask Aime
What guidance did Cartesian Therapeutics's management provide for the next earnings period?What factors drove the changes in Cartesian Therapeutics's revenue and profit?What were the key takeaways from Cartesian Therapeutics’s earnings call?What is the market's earnings forecast for Cartesian Therapeutics next quarter?What is Cartesian Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Cartesian Therapeutics's earnings call?Did Cartesian Therapeutics beat or miss consensus estimates last quarter?What does Cartesian Therapeutics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
